TBC1D3F

Across TCGA pan-cancer cohorts, TBC1D3F Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated TBC1D3F data layer compared with 21 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher TBC1D3F Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated TBC1D3F expression acts as an unfavorable survival marker.

SKCM and THYM are the cancer types where TBC1D3F Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Median	All	0.023	0.738	<.001	6	view →
THYM	OS	Median	II,III,IV	0.395	0.863	.014	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

TBC1D3F–SKCM (DFS)

Open the SKCM breakdown →